Stenahm Asset Management’s ESSA Pharma EPIX Stock Holding History

Stenahm Asset Management’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-104,000	Closed	-$832K	–	24
2021 Q3	$832K	Hold	104,000	–	–	0.54%	20
2021 Q2	$2.97M	Sell	104,000 -43,113	-29%	-$1.25M	1.82%	22
2021 Q1	$4.27M	Buy	+147,113	New	+$3.42M	3.01%	16

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Stenahm Asset Management's EPIX Position: Q4 2021 in Review

Stenahm Asset Management sold out of ESSA Pharma (EPIX) in Q4 2021, closing a stake of 104,000 shares — an estimated $832K sold.

Stenahm Asset Management first reported a position in EPIX in Q1 2021 and held it in 3 quarters. The position peaked at $4.27M in Q1 2021. 60 funds tracked by Wall St. Rank hold EPIX as of Q4 2021.

Stenahm Asset Management reported no remaining ESSA Pharma position as of Q4 2021 after selling out during the quarter.
Stenahm Asset Management sold 104,000 ESSA Pharma shares in Q4 2021, an estimated $832K.
Stenahm Asset Management first reported a position in ESSA Pharma in Q1 2021 and held it in 3 quarters.
Stenahm Asset Management's ESSA Pharma position peaked at $4.27M in Q1 2021.
60 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2021.

Based on Stenahm Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.